Twist Bioscience Corporation

NASDAQ
TWST
Stock
Yield per half year: -34.17%
Dividend yield: 0%
Sector: Healthcare

26.57 $

-0.18 $ ( 0.6729%)
24.16 $
54.07 $

Min/max per year

Share chart Twist Bioscience Corporation

Main settings

Currency
usd
Dividend income of JSC
0
IPO Time
2018-10-31
ISIN
US90184D1000
Industry
Biotechnology
Report Currency
usd
Sector
Health Care
Website

Grade

Underestimation
Title Value Grade
P/S 8.38 1
P/BV 5.55 2
P/E -7.63 0
Efficiency
Title Value Grade
ROA -30.02 0
ROE -38.08 0
ROIC -23.64 0
Dividends
Title Value Grade
Dividend yield 0 0
DSI 0 0
Average dividend growth 0 0
Debt
Title Value Grade
Debt/EBITDA -0.4812 10
Debt/Ratio 0.1384 10
Debt/Equity 0.2996 10
Growth impulse
Title Value Grade
Revenue, bln, % 247.36 10
Ebitda, % 51.94 7
EPS, % 0.7768 1

Prices

Price Min. Max. Change Changes in the industry Changes in the index
Yesterday 26.75 $ 0 $ 0 $ -0.6729 % 0 % 0 %
Week 27.89 $ 0 $ 0 $ -4.73 % 0 % 0 %
Month 27.19 $ 24.16 $ 27.95 $ -2.28 % 0 % 0 %
Three month 35.93 $ 24.16 $ 39.12 $ -26.05 % 0 % 0 %
Half a year 40.36 $ 24.16 $ 40.17 $ -34.17 % 0 % 0 %
Year 44.17 $ 24.16 $ 54.07 $ -39.85 % 0 % 0 %
3 years 98.17 $ 11.49 $ 58.88 $ -72.93 % 0 % 0 %
5 years 24.09 $ 11.49 $ 207.97 $ +10.29 % 0 % 0 %
10 years 11.49 $ 11.49 $ 207.97 $ +231.24 % 0 % 0 %
Year to date 47.94 $ 24.16 $ 54.07 $ -44.58 % 0 % 0 %

Insider trading

Main owners

Contained in ETF

ETF
Share, %
Profitability for 1 year, %
Commission, %
Global X Telemedicine & Digital Health ETF Registered 3.73609 -8.96 0.68
Future Tech ETF 0.26233 479.5 0.35
Principal Healthcare Innovators ETF 0.26233 -3.92 0.35
iShares Morningstar Small-Cap Growth ETF 0.10798 519.61 0.06
iShares Morningstar Small-Cap ETF 0.05453 270.73 0.25
0.88251.390.34

Similar companies



Company management

Head Job title Payment Year of birth
Mr. Siyuan Chen Chief Technology Officer N/A
Ms. Paula Green Senior Vice President of Human Resources 618.48k 1968 (57 years)
Dr. Emily Marine Leproust Ph.D. Co-Founder, Chairman & CEO 1.37M 1973 (52 years)
Dr. William Charles Banyai Ph.D. Senior VP of Advanced Development, GM of Data Storage & Director 711.34k 1955 (70 years)
Dr. Patrick John Finn Ph.D. President & COO 943.94k 1972 (53 years)
Dr. Aaron K. Sato Ph.D. Chief Scientific Officer N/A
Mr. Dennis Cho Senior VP, Chief Legal Officer & Corporate Secretary 537.93k 1971 (54 years)
Mr. Robert F. Werner VP & Chief Accounting Officer N/A 1973 (52 years)
Mr. Chet Gandhi Chief Information Officer N/A
Mr. Adam Laponis Chief Financial Officer N/A 1977 (48 years)

About company

Address: United States, South San Francisco, 681 Gateway Boulevard - Open in google maps, Open in yandex maps
Website: http://www.twistbioscience.com

About Twist Bioscience Corporation

Twist Bioscience Corporation, компания по синтетической биологии, производит и продает продукты на основе синтетической ДНК. Платформа синтеза ДНК компании позволяет производить синтетическую ДНК путем записи ДНК на кремниевый чип. Он предлагает продукты на основе синтетической ДНК, включая синтетические гены, инструменты для подготовки образцов, библиотеки антител для обнаружения и разработки лекарств, а также ДНК в качестве цифрового носителя данных. Компания имеет соглашение о сотрудничестве с компанией ImmunoPrecise Antibodies Ltd. Корпорация Twist Bioscience была основана в 2013 году со штаб-квартирой в Южном Сан-Франциско, штат Калифорния.